Related Experiment Video
Updated: Jul 17, 2026

Retinal Pathophysiological Evaluation in a Rat Model
Published on: May 6, 2022
Retinal penetration of calpain inhibitors in rats after oral administration
Yoshihisa Shirasaki1, Masazumi Yamaguchi, Hiroyuki Miyashita
1Pharmacokinetic group, Laboratory for Preclinical Research, Senju Pharmaceutical Co., Ltd., Hyogo, Japan. shirasaki@senju.co.jp
Abstract:
Calpain-mediated proteolysis has been involved in neuronal cell death of retinal neurological degeneration. An aldehyde-based calpain inhibitor, SJA6017 (1), was effective following oral administration in a rat retinal ischemia model but had low oral bioavailability. The aim of this study was to identify calpain inhibitors with good retinal penetration after oral dosing. The orally bioavailable inhibitors, hemiacetal 3 (SNJ-1715), amphipathic ketoamide 5 (SNJ-1945), and pyridine ketoamide 6 (SNJ-2008), were evaluated for their retinal pharmacokinetic (PK) profiles. The retinal drug exposure of these inhibitors was more than tenfold higher than 1. Among these compounds, 5 exhibited the most favorable retinal PK properties, such as good penetration and long half-life. Comparisons of 5 and the structurally related ketoamide 6 suggested that the presence of a methoxy diethylene glycol moiety resulted in the inhibitor with high penetration into the retina and the sustained high retinal levels. Ketoamide 5 was selected as the development candidate for the treatment of retinal diseases.

